Indian Bulk Drug Market - Industry Insight

Brochure More information from http://www.researchandmarkets.com/reports/1405101/ Indian Bulk Drug Market - Industry Insight Description: Indian bul...
5 downloads 2 Views 51KB Size
Brochure More information from http://www.researchandmarkets.com/reports/1405101/

Indian Bulk Drug Market - Industry Insight Description:

Indian bulk drug industry to grow to US$ 17 billion by 2014 The Indian Bulk Drug industry is expected to grow at a CAGR of 21% to reach US$16.91 billion by 2013-14 as per this study. Cygnus estimates the size of the Indian bulk drug industry for 2009-10 at US$ 11.54 billion, out of which exports contribute about US$ 7.5 billion, constituting 65% of the industry. The Indian Contract Manufacturing market stood at US$986m in 2009 and is expected to grow at a CAGR of 41.7% to reach US$5.63 billion by 2014. India has the highest number of Drug Master Filings (DMF) amongst all key competing economies. From 2000-2008 India had more than 1614 filings, 3 times higher than that of China. Other Countries such as Italy, Spain, Mexico, Brazil etc are far behind as compared to India. The share of Drug Master Filings made by Indian firms has increased considerably from 14% in 2000 to 50% in 2009. In view of the significant growth potential of the Indian bulk drugs industry, Cygnus releases the latest version of the Indian Bulk Drugs Industry Insight. The report will be useful to senior executives associated with the industry, bankers, private equity players, investors, students, research scholars and industry analysts who need relevant industry inputs for their work. SCOPE OF THE REPORT - Global and Indian Bulk Drug Market - Key Growth Drivers - Industry Regulations - Issues & Challenges - Major Players – Business profile, Their Bulk Actives therapeutic segment wise, Strategies, M& A / Alliances, Financial Profile, SWOT Analysis and Future Outlook. - Major Medical Institutes - Critical Success Factors - Future outlook HIGHLIGHTS OF THE REPORT - Major therapeutic categories and Annual Production of Major Bulk Drugs - Major Deals Announced/Completed By Indian Companies - Drug Patent Expirations - ANDA Filings by Indian Companies - R&D Expenditure - DMF filings by Indian companies - India's Advantages for Contract Manufacturing - A Comparison between India and China - 320 DMF filings by Indian companies - List of Bulk Drugs Manufacturers in India REASONS TO BUY - Latest and Very Comprehensive report on Indian API Market - Gives insights into Indian Pharma industry also along with the outsourcing market - Lists of various sought after Data such as patent expirations, DMF, import - export etc RELATED REPORTS Indian Pharmaceutical Markets, Quarterly Update & Analysis on Indian Pharma, Indian Dental Market, Clinical Trials in India, CRAMS Market

Contents:

1. Executive Summary 2. Highlights 3. Global Bulk drugs Market - Market Overview 3.1. Introduction

3.2 Global Bulk Drugs Market 4. Indian Bulk Drugs Market - an Overview 4.1 Indian Pharmaceutical Market 4.2 Indian Bulk Drugs 4.3 Growth Trends 4.4 Future outlook 5. Growth Drivers 5.1 High Growth of Generics / Patent expiries 5.2 New Drug Developments 5.3 Contract Manufacturing 5.4 Overall Pharmaceutical Growth 5.5 Reduced Manufacturing cost 6. Industry Regulations 6.1 Budget measures 6.2 Policy changes 6.3 Regulatory Bodies 6.4 Pharmaceutical Policy-2002 6.5 National pharmaceutical policy 2006 6.6 Pricing of Scheduled Bulk Drugs 6.7 Indian Patent law 6.8 Labelling System in India 6.9 Intellectual Property Rights (IPR) 6.10 Trade Related Aspects of Intellectual Property Rights (TRIPS) 6.11 Bulk drugs prices come under NPPA lens 7. Issues & Challenges 7.1 Increasing Competition 7.2 Coping with Changing Disease Profile 7.3 Over Capacity 7.4 Undifferentiated Capabilities 7.5 Varying regulatory requirements lead to additional costs 7.6 Threat from China 8. Major Players 8.1 Aurobindo Pharma 8.2 Ranbaxy Laboratories 8.3 Dr. Reddy's Laboratories 8.4 Lupin Ltd 8.5 Matrix Laboratories 8.6 Cipla Ltd 8.7 Orchid Chemicals and Pharmaceuticals Ltd. 8.8 Divis laboratories 8.9 Sun Pharmaceutical Industries Ltd 8.10 Ipca Laboratories Ltd. 8.11 Dishman Pharmaceutical and Chemicals Ltd 8.12 Cadila Healthcare Ltd 8.13 Alembic Ltd 8.14. Glaxo SmithKline Pharmaceuticals Ltd. 8.15 Glenmark Pharmaceuticals Ltd. 8.16 Piramal Healthcare Limited (PHL) 8.17 Unichem Laboratories Ltd 8.18 Merck India Ltd. 8.19 Atul Ltd 9. Critical Success Factors 9.1 Low-Cost Manufacturing Skills 9.2 Striking Strategic Alliances (Mergers & Acquisitions) 9.3 Growing Experience with cGMP Compliance 9.4 Complex Synthesis Capabilities 9.5 Identifying New Opportunities Holds the Key for Generic Manufacturers 9.6 Indian Companies enter in to Global Cancer Drugs Market 9.7 Focus on New therapeutic Segments 9.8 Time the Market 9.9 Accreditations 10. Future Outlook Annexure 1: List of Abbreviations

Annexure 2: DMF filings by Indian companies Annexure 3: List of Bulk Drugs Manufacturers in India Annexure 4: List of Industry Organizations Annexure 5: Bibilography List of Figures Figure 3.1: Global pharmaceutical market value (2005-2009) Figure 3.2: Global Market Share in % (2009) Figure 3.3: Global Bulk Drugs Market Size (2006-10) Figure 4.1: Indian Domestic Pharmaceutical Market Figure 4.2: Major Therapeutic Segments as% Contribution (2008-09) Figure 4.3: Vision 2010: Glimpse of Indian Pharmaceutical Market Future Figure 4.4: Total Market Size (2004-09) Figure 4.5: Exports Vs Exports (%) to total Figure 4.6: Indian bulk drugs Imports Figure 5.1: Global Contract Manufacturing Market List of Tables Table 1: Leading Therapeutic Segments 2009 Table 2: Leading Brands 2009 Table 3: Major Markets 2009 Table 4: Market Segment (US$ bn) Table 5: Global Major Players Table 6: Major Acquisition in 2005-10 Table 7: Annual Production of Major Bulk Drugs Table 8: Major Deals Announced/Completed By Indian Companies Table 9: ANDA Filings by Indian Companies Table 10: R&D Expenditure 2008-09 Table 11: DMF filings by Indian companies Table 12: India's Advantages for Contract Manufacturing Table 13: Comparison between India and China

Ordering:

Order Online - http://www.researchandmarkets.com/reports/1405101/ Order by Fax - using the form below Order by Post - print the order form below and send to Research and Markets, Guinness Centre, Taylors Lane, Dublin 8, Ireland.

Page 1 of 2 Fax Order Form To place an order via fax simply print this form, fill in the information below and fax the completed form to 646-607-1907 (from USA) or +353-1-481-1716 (from Rest of World). If you have any questions please visit http://www.researchandmarkets.com/contact/

Order Information Please verify that the product information is correct and select the format(s) you require. Product Name:

Indian Bulk Drug Market - Industry Insight

Web Address:

http://www.researchandmarkets.com/reports/1405101/

Office Code:

SC

Product Formats Please select the product formats and quantity you require: Quantity Electronic (PDF) Single User:

USD 945

Electronic (PDF) Enterprisewide:

USD 2835

* The price quoted above is only valid for 30 days. Please submit your order within that time frame to avail of this price as all prices are subject to change.

Contact Information Please enter all the information below in BLOCK CAPITALS Title: First Name:

Mr

Mrs

Dr

Miss Last Name:

Email Address: * Job Title: Organisation: Address: City: Postal / Zip Code: Country: Phone Number: Fax Number: * Please refrain from using free email accounts when ordering (e.g. Yahoo, Hotmail, AOL)

Ms

Prof

Page 2 of 2 Payment Information Please indicate the payment method you would like to use by selecting the appropriate box. Pay by credit card:

You will receive an email with a link to a secure webpage to enter your credit card details.

Pay by check:

Please post the check, accompanied by this form, to: Research and Markets, Guinness Center, Taylors Lane, Dublin 8, Ireland.

Pay by wire transfer:

Please transfer funds to: Account number

833 130 83

Sort code

98-53-30

Swift code

ULSBIE2D

IBAN number

IE78ULSB98533083313083

Bank Address

Ulster Bank, 27-35 Main Street, Blackrock, Co. Dublin, Ireland.

If you have a Marketing Code please enter it below: Marketing Code: Please note that by ordering from Research and Markets you are agreeing to our Terms and Conditions at http://www.researchandmarkets.com/info/terms.asp

Please fax this form to: (646) 607-1907 or (646) 964-6609 - From USA +353-1-481-1716 or +353-1-653-1571 - From Rest of World